drugset / Trial / NCT02875587
Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome
RandomizedParallel-groupSingle-blindPrevention
Summary
The aim of this study is to compare the efficacy of calcium gluconate infusion versus cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in patients pretreated with GnRH agonist long protocol who are at high risk for OHSS.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-08
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cabergoline | Small molecule | 0.5 mg | Oral |
| Subject | calcium gluconate | Small molecule | 10 ml | Intravenous |